Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Kerridge

Showing results (241-250 of 308) with videos related to

Pageof 31
Sort By:
Internal Medicine Journal|June 19, 2022
Unusual presentations of central nervous system myeloid sarcomaSophie Chatterton, Jacob Helou, James Drummond, et al.
Sociology of Health & Illness|February 22, 2024
Choreographing a good death: Carers' experiences and practices of enacting assisted dyingSophie Lewis, Camille La Brooy, Ian Kerridge, et al.
European Journal of Human Genetics : EJHG|January 22, 2021
Identifying the nature and extent of public and donor concern about the commercialisation of biobanks for genomic researchChristine R Critchley, Jennifer Fleming, Dianne Nicol, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2020
Hematopoietic Stem Cell Transplant Recipients Surviving at Least 2 Years from Transplant Have Survival Rates Approaching Population Levels in the Modern Era of TransplantationDavid Kliman, Ian Nivison-Smith, David Gottlieb, et al.
Internal Medicine Journal|February 2, 2021
Death determination, organ donation and the importance of the Dead Donor Rule following withdrawal of life-sustaining treatment: a survey of community opinionsMichael J O'Leary, George Skowronski, Christine Critchley, et al.
Australian Health Review : a Publication of the Australian Hospital Association|November 19, 2020
Biobank networking and globalisation: perspectives and practices of Australian biobanksEdwina Light, Miriam Wiersma, Lisa Dive, et al.
Journal of Clinical Apheresis|June 20, 2014
Factors determining pbsc mobilization efficiency and nonmobilization following ICE with or without rituximab (R-ICE) salvage therapy for refractory or relapsed lymphoma prior to autologous transplantationWei Xia, Chun Kei K Ma, Cassandra Reid, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2017
Serum levels, safety and tolerability of new formulation SUBA-itraconazole prophylaxis in patients with haematological malignancy or undergoing allogeneic stem cell transplantationJulian Lindsay, Indy Sandaradura, Kelly Wong, et al.
BMC Medical Ethics|August 18, 2020
Public trust and global biobank networksLisa Dive, Christine Critchley, Margaret Otlowski, et al.
Journal of Law and Medicine|March 9, 2024
Conscientious Objection and Institutional Objection to Voluntary Assistance in Dying: An Ethico-legal CritiqueIan Kerridge, Cameron Stewart, Jackie Leach Scully, et al.
Pageof 31

Showing results (241-250 of 308) with videos related to

Sort By:
Pageof 31
Internal Medicine Journal|June 19, 2022
Unusual presentations of central nervous system myeloid sarcomaSophie Chatterton, Jacob Helou, James Drummond, et al.
Sociology of Health & Illness|February 22, 2024
Choreographing a good death: Carers' experiences and practices of enacting assisted dyingSophie Lewis, Camille La Brooy, Ian Kerridge, et al.
European Journal of Human Genetics : EJHG|January 22, 2021
Identifying the nature and extent of public and donor concern about the commercialisation of biobanks for genomic researchChristine R Critchley, Jennifer Fleming, Dianne Nicol, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2020
Hematopoietic Stem Cell Transplant Recipients Surviving at Least 2 Years from Transplant Have Survival Rates Approaching Population Levels in the Modern Era of TransplantationDavid Kliman, Ian Nivison-Smith, David Gottlieb, et al.
Internal Medicine Journal|February 2, 2021
Death determination, organ donation and the importance of the Dead Donor Rule following withdrawal of life-sustaining treatment: a survey of community opinionsMichael J O'Leary, George Skowronski, Christine Critchley, et al.
Australian Health Review : a Publication of the Australian Hospital Association|November 19, 2020
Biobank networking and globalisation: perspectives and practices of Australian biobanksEdwina Light, Miriam Wiersma, Lisa Dive, et al.
Journal of Clinical Apheresis|June 20, 2014
Factors determining pbsc mobilization efficiency and nonmobilization following ICE with or without rituximab (R-ICE) salvage therapy for refractory or relapsed lymphoma prior to autologous transplantationWei Xia, Chun Kei K Ma, Cassandra Reid, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2017
Serum levels, safety and tolerability of new formulation SUBA-itraconazole prophylaxis in patients with haematological malignancy or undergoing allogeneic stem cell transplantationJulian Lindsay, Indy Sandaradura, Kelly Wong, et al.
BMC Medical Ethics|August 18, 2020
Public trust and global biobank networksLisa Dive, Christine Critchley, Margaret Otlowski, et al.
Journal of Law and Medicine|March 9, 2024
Conscientious Objection and Institutional Objection to Voluntary Assistance in Dying: An Ethico-legal CritiqueIan Kerridge, Cameron Stewart, Jackie Leach Scully, et al.
Pageof 31